A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
The third essential use involves assessing patient eligibility for PSMA targeted radionuclide therapy. Although a contrast CT ...
Everyday Health on MSN
Prostate Cancer With Bone Metastases: Your Questions Answered
The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases ...
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI ...
Adverse Effects of Robotic-Assisted Laparoscopic Versus Open Retropubic Radical Prostatectomy Among a Nationwide Random Sample of Medicare-Age Men There is currently no imaging biomarker for ...
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of ...
When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results